SERHAN CHARLES N has a total of 21 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are OSTEOLOGIX AS, DIFFUSION PHARMACEUTICALS LLC and SYNDROMEX LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 21 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Serhan Charles N | 21 |
#2 | Levy Bruce D | 5 |
#3 | Dana Reza | 3 |
#4 | Jin Yiping | 3 |
#5 | Yang Rong | 2 |
#6 | Petasis Nicos A | 2 |
#7 | Yoshida Masaru | 1 |
#8 | Norling Lucy V | 1 |
#9 | Arita Makoto | 1 |
#10 | Blumberg Richard | 1 |
Publication | Filing date | Title |
---|---|---|
US2015025257A1 | Docosahexaenoyl ethanolamides | |
US2012010286A1 | Prevention of neutrophil recruitment | |
US2014094519A1 | Lipoxin analogs as novel inhibitors of angiogenesis | |
US2010105772A1 | Use of novel lipid mediators to inhibit angiogenesis | |
US2011301239A1 | Use of novel lipid mediators to inhibit angiogenesis | |
US2009156673A1 | Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers | |
US2006293288A1 | Use of resolvins to treat gastrointestinal diseases |